657
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma

, , , ORCID Icon, ORCID Icon, , , , , , & show all
Received 16 Nov 2022, Accepted 26 Mar 2024, Published online: 02 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.